RankingsPricing
  1. JP-listed companies
  2. TAKARA BIO INC.
  3. Financials
  4. Accounts receivable, net

TAKARA BIO INC.【JP:4974】

Market cap
¥97.8B
P/E ratio
-10.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndAccounts receivable, net (Million JPY)YoY (%)
Mar 31, 202112,626+38.72%
Mar 31, 20209,102+5.79%
Mar 31, 20198,604+7.13%
Mar 31, 20188,031+7.73%
Mar 31, 20177,455+9.15%
Mar 31, 20166,830+1.32%
Mar 31, 20156,741

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)